Your browser doesn't support javascript.
loading
Using structural MRI to identify bipolar disorders - 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group.
Nunes, Abraham; Schnack, Hugo G; Ching, Christopher R K; Agartz, Ingrid; Akudjedu, Theophilus N; Alda, Martin; Alnæs, Dag; Alonso-Lana, Silvia; Bauer, Jochen; Baune, Bernhard T; Bøen, Erlend; Bonnin, Caterina Del Mar; Busatto, Geraldo F; Canales-Rodríguez, Erick J; Cannon, Dara M; Caseras, Xavier; Chaim-Avancini, Tiffany M; Dannlowski, Udo; Díaz-Zuluaga, Ana M; Dietsche, Bruno; Doan, Nhat Trung; Duchesnay, Edouard; Elvsåshagen, Torbjørn; Emden, Daniel; Eyler, Lisa T; Fatjó-Vilas, Mar; Favre, Pauline; Foley, Sonya F; Fullerton, Janice M; Glahn, David C; Goikolea, Jose M; Grotegerd, Dominik; Hahn, Tim; Henry, Chantal; Hibar, Derrek P; Houenou, Josselin; Howells, Fleur M; Jahanshad, Neda; Kaufmann, Tobias; Kenney, Joanne; Kircher, Tilo T J; Krug, Axel; Lagerberg, Trine V; Lenroot, Rhoshel K; López-Jaramillo, Carlos; Machado-Vieira, Rodrigo; Malt, Ulrik F; McDonald, Colm; Mitchell, Philip B; Mwangi, Benson.
Afiliação
  • Nunes A; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Schnack HG; Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Ching CRK; Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Agartz I; Interdepartmental Neuroscience Program, University of California, Los Angeles, CA, USA.
  • Akudjedu TN; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Marina del Rey, CA, USA.
  • Alda M; NORMENT KG Jebsen Centre, University of Oslo, Oslo, Norway.
  • Alnæs D; Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Alonso-Lana S; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Bauer J; Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, Stockholm, Sweden.
  • Baune BT; Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Bøen E; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Bonnin CDM; NORMENT KG Jebsen Centre, University of Oslo, Oslo, Norway.
  • Busatto GF; Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Canales-Rodríguez EJ; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
  • Cannon DM; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
  • Caseras X; Institute of Clinical Radiology, Medical Faculty - University of Muenster - and University Hospital Muenster, Muenster, Germany.
  • Chaim-Avancini TM; Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia.
  • Dannlowski U; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Díaz-Zuluaga AM; Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Dietsche B; Laboratory of Psychiatric Neuroimaging (LIM-21), Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
  • Doan NT; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo, São Paulo, Brazil.
  • Duchesnay E; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
  • Elvsåshagen T; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
  • Emden D; Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Eyler LT; MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
  • Fatjó-Vilas M; Laboratory of Psychiatric Neuroimaging (LIM-21), Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
  • Favre P; Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo, São Paulo, Brazil.
  • Foley SF; Department of Psychiatry, University of Münster, Münster, Germany.
  • Fullerton JM; Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Antioquia, Colombia.
  • Glahn DC; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Goikolea JM; NORMENT KG Jebsen Centre, University of Oslo, Oslo, Norway.
  • Grotegerd D; Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Hahn T; NeuroSpin, CEA, Paris-Saclay, Gif sur Yvette, France.
  • Henry C; NORMENT KG Jebsen Centre, University of Oslo, Oslo, Norway.
  • Hibar DP; Department of Neurology, Oslo Universisty Hospital, Oslo, Norway.
  • Houenou J; Department of Psychiatry, University of Münster, Münster, Germany.
  • Howells FM; Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
  • Jahanshad N; Desert-Pacific Mental Illness Research, Education, and Clinical Center, VA San Diego Healthcare System, La Jolla, CA, USA.
  • Kaufmann T; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
  • Kenney J; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
  • Kircher TTJ; Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
  • Krug A; NeuroSpin, CEA, Paris-Saclay, Gif sur Yvette, France.
  • Lagerberg TV; Cardiff University Brain Research Imaging Centre, Cardiff University, Cardiff, UK.
  • Lenroot RK; Neuroscience Research Australia, Sydney, NSW, Australia.
  • López-Jaramillo C; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Machado-Vieira R; Department of Psychiatry, Yale University, New Haven, CT, USA.
  • Malt UF; Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA.
  • McDonald C; Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Mitchell PB; Department of Psychiatry, University of Münster, Münster, Germany.
  • Mwangi B; Department of Psychiatry, University of Münster, Münster, Germany.
Mol Psychiatry ; 25(9): 2130-2143, 2020 09.
Article em En | MEDLINE | ID: mdl-30171211
ABSTRACT
Bipolar disorders (BDs) are among the leading causes of morbidity and disability. Objective biological markers, such as those based on brain imaging, could aid in clinical management of BD. Machine learning (ML) brings neuroimaging analyses to individual subject level and may potentially allow for their diagnostic use. However, fair and optimal application of ML requires large, multi-site datasets. We applied ML (support vector machines) to MRI data (regional cortical thickness, surface area, subcortical volumes) from 853 BD and 2167 control participants from 13 cohorts in the ENIGMA consortium. We attempted to differentiate BD from control participants, investigated different data handling strategies and studied the neuroimaging/clinical features most important for classification. Individual site accuracies ranged from 45.23% to 81.07%. Aggregate subject-level analyses yielded the highest accuracy (65.23%, 95% CI = 63.47-67.00, ROC-AUC = 71.49%, 95% CI = 69.39-73.59), followed by leave-one-site-out cross-validation (accuracy = 58.67%, 95% CI = 56.70-60.63). Meta-analysis of individual site accuracies did not provide above chance results. There was substantial agreement between the regions that contributed to identification of BD participants in the best performing site and in the aggregate dataset (Cohen's Kappa = 0.83, 95% CI = 0.829-0.831). Treatment with anticonvulsants and age were associated with greater odds of correct classification. Although short of the 80% clinically relevant accuracy threshold, the results are promising and provide a fair and realistic estimate of classification performance, which can be achieved in a large, ecologically valid, multi-site sample of BD participants based on regional neurostructural measures. Furthermore, the significant classification in different samples was based on plausible and similar neuroanatomical features. Future multi-site studies should move towards sharing of raw/voxelwise neuroimaging data.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article